Metabolon: The Leader in Metabolomics
Metabolon is a pioneer and leader in metabolomics
- an integrative, powerful phenotyping technology for assessing health.
Its proprietary platforms and informatics systems are delivering
biomarker discoveries, innovative diagnostic tests, breakthroughs in
precision medicine, and robust partnerships in genomics-based health
We offer scalable, customizable research services
to academic and commercial investigators in every area of the life
sciences. We are also using our technology to advance precision medicine
and develop novel metabolomics-based clinical diagnostic tests that may improve early detection of diseases.
Innovation Powered by Proprietary Technology
Our experienced team of Ph.D. scientists, biostatisticians and informaticists has created the industry’s most comprehensive metabolomics platform (DiscoveryHD4™). We also offer a suite of focused panels and customizable targeted assays, which are useful for validating hypotheses or exploring a particular metabolite or metabolite class.
Metabolon has developed novel clinical diagnostic tests derived from our metabolomics expertise. Our laboratory-developed tests (LDTs) include Quantose IR™ (a blood test for gauging early-stage insulin resistance) and Quantose IGT™ (a blood test that measures impaired glucose tolerance). Quantose IR was the first metabolomics-based LDT on the market and is currently available in the U.S., Mexico and Europe. Quantose IGT is available as an LDT in the U.S. Our growing diagnostics pipeline is focused on obesity-related diseases.
Unmatched Experience & Expertise
Since its founding in 2000, Metabolon has served nearly 700 clients from both industry and academia, and we have formed strategic partnerships
with several major research institutions, as well as many
pharmaceutical, agricultural, bioprocessing and consumer goods
We currently have over 160 highly qualified employees, including more
than 40 Ph.D.s from diverse backgrounds in molecular biology and
biochemistry, and an experienced staff of statisticians,
bioinformaticians, chemists, software developers and engineers. With
more than 4,000 completed projects behind us, our institutional
knowledge is unmatched in the industry.
In addition, the staff at Metabolon has written and contributed to
nearly 500 peer-reviewed journal publications, including numerous
articles in Cell, Nature and Science. Our publications and studies can be reviewed in the Resources section of this website.